New randomized, controlled trials “are needed” that compare metabolic bariatric surgery with medical and lifestyle management that includes “high-dose incretin-hormone therapy,” commented Robert H. Eckel, an endocrinologist and emeritus professor at the University of Colorado School of Medicine in Aurora.
CU Anschutz
Academic Office One
12631 East 17th Avenue
8601
Aurora, CO 80045